Transition for adolescents with a rare disease: results of a nationwide German project.

Adolescent health Empowerment Health literacy Pathway Rare disease Transition

Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
25 04 2023
Historique:
received: 22 09 2022
accepted: 06 04 2023
medline: 27 4 2023
pubmed: 26 4 2023
entrez: 25 4 2023
Statut: epublish

Résumé

The transition process from paediatric/adolescent to adult medical care settings is of utmost importance for the future health of adolescents with chronic diseases and poses even more difficulties in the context of rare diseases (RDs). Paediatric care teams are challenged to deliver adolescent-appropriate information and structures. Here we present a structured transition pathway which is patient-focused and adoptable for different RDs. The transition pathway for adolescents 16 years and older was developed and implemented as part of a multi-centre study in 10 university hospitals in Germany. Key elements of the pathway included: assessment of patients' disease-related knowledge and needs, training/educational and counselling sessions, a structured epicrisis and a transfer appointment jointly with the paediatric and adult specialist. Specific care coordinators from the participating university hospitals were in charge of organization and coordination of the transition process. Of a total of 292 patients, 286 completed the pathway. Deficits in disease-specific knowledge were present in more than 90% of participants. A need for genetic or socio-legal counselling was indicated by > 60%. A mean of 2.1 training sessions per patient were provided over a period of almost 1 year, followed by the transfer to adult care in 267 cases. Twelve patients remained in paediatric care as no adult health care specialist could be identified. Targeted training and counselling resulted in improved disease-specific knowledge and contributed to empowering of patients. The described transition pathway succeeds to improve health literacy in adolescents with RDs and can be implemented by paediatric care teams in any RD specialty. Patient empowerment was mainly achieved by individualized training and counselling.

Identifiants

pubmed: 37098531
doi: 10.1186/s13023-023-02698-2
pii: 10.1186/s13023-023-02698-2
pmc: PMC10131406
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

93

Informations de copyright

© 2023. The Author(s).

Références

Arch Dis Child. 1997 Aug;77(2):115-9
pubmed: 9301348
Pediatrics. 2011 Jul;128(1):182-200
pubmed: 21708806
Patient Educ Couns. 2010 Jun;79(3):277-82
pubmed: 19682830
Lancet. 2007 Apr 28;369(9571):1481-1489
pubmed: 17467519
Diabetes Care. 2008 Aug;31(8):1529-30
pubmed: 18458141
Lancet Child Adolesc Health. 2021 Jan;5(1):9-11
pubmed: 33065001
BMC Health Serv Res. 2013 Jul 08;13:263
pubmed: 23835131
Rare Dis. 2013 Jan 28;1:e23579
pubmed: 25002987
Arthritis Care Res. 1991 Dec;4(4):174-80
pubmed: 11188605
Syst Rev. 2016 Sep 29;5(1):166
pubmed: 27686735
Epilepsy Behav. 2019 Apr;93:133-137
pubmed: 30626546
Pediatr Nephrol. 2000 Jun;14(6):469-72
pubmed: 10872185
Can J Cardiol. 2009 Sep;25(9):e317-22
pubmed: 19746251
Lancet Child Adolesc Health. 2017 Dec;1(4):274-283
pubmed: 30169183
Lancet Child Adolesc Health. 2017 Dec;1(4):251-253
pubmed: 30169176
BMC Gastroenterol. 2019 Jul 19;19(1):128
pubmed: 31324228
Br J Community Nurs. 2009 Jul;14(7):301-4
pubmed: 19597382
Dtsch Arztebl Int. 2022 Jul 11;119(27-28):469-475
pubmed: 35635437
Pediatrics. 2018 Mar;141(Suppl 3):S233-S241
pubmed: 29496974
BMC Health Serv Res. 2015 Jul 01;15:252
pubmed: 26126998
J Adolesc Health. 1993 Nov;14(7):570-6
pubmed: 8312295
Pediatrics. 2002 Dec;110(6 Pt 2):1304-6
pubmed: 12456949
Clin Pediatr (Phila). 2017 Mar;56(3):278-283
pubmed: 27178828
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Jun;55(6-7):836-42
pubmed: 22736165
BMJ Open. 2017 Jun 12;7(6):e015593
pubmed: 28606904
BMJ Open. 2017 Apr 17;7(4):e014593
pubmed: 28420661

Auteurs

Corinna Grasemann (C)

Division of Rare Diseases, Department of Paediatrics, St. Josef-Hospital Bochum, Ruhr-University Bochum, Alexandrinenstraße 5, 44791, Bochum, Germany. corinna.grasemann@rub.de.
Centre for Rare Diseases Ruhr CeSER, Ruhr-University Bochum and Witten/Herdecke University, Bochum, Germany. corinna.grasemann@rub.de.

Jakob Höppner (J)

Division of Rare Diseases, Department of Paediatrics, St. Josef-Hospital Bochum, Ruhr-University Bochum, Alexandrinenstraße 5, 44791, Bochum, Germany.

Peter Burgard (P)

Centre for Child and Adolescent Medicine and and Centre for Rare Diseases, University Hospital Heidelberg, Heidelberg, Germany.

Michael M Schündeln (MM)

Department of Paediatrics III, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Nora Matar (N)

Division of Rare Diseases, Department of Paediatrics, St. Josef-Hospital Bochum, Ruhr-University Bochum, Alexandrinenstraße 5, 44791, Bochum, Germany.
Centre for Rare Diseases Ruhr CeSER, Ruhr-University Bochum and Witten/Herdecke University, Bochum, Germany.

Gabriele Müller (G)

Centre for Evidence-Based Healthcare, Carl Gustav Carus Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Heiko Krude (H)

Institute for Experimental Paediatric Endocrinology and Centre for Rare Diseases, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Reinhard Berner (R)

Children's Department and University Centre for Rare Diseases (USE), University Hospital Dresden, Dresden, Germany.

Min Ae Lee-Kirsch (MA)

Children's Department and University Centre for Rare Diseases (USE), University Hospital Dresden, Dresden, Germany.

Fabian Hauck (F)

Dr von Hauner Children's Hospital, University Hospital and Munich Centre for Rare Diseases (M-ZSELMU), Ludwig-Maximilians-University Munich, Munich, Germany.

Kerstin Wainwright (K)

Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Sylvana Baumgarten (S)

Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Janet Atinga (J)

Division of Rare Diseases, Department of Paediatrics, St. Josef-Hospital Bochum, Ruhr-University Bochum, Alexandrinenstraße 5, 44791, Bochum, Germany.
Centre for Rare Diseases Ruhr CeSER, Ruhr-University Bochum and Witten/Herdecke University, Bochum, Germany.

Jens J Bauer (JJ)

Division of Rare Diseases, Department of Paediatrics, St. Josef-Hospital Bochum, Ruhr-University Bochum, Alexandrinenstraße 5, 44791, Bochum, Germany.
Centre for Rare Diseases Ruhr CeSER, Ruhr-University Bochum and Witten/Herdecke University, Bochum, Germany.

Eva Manka (E)

Department of Paediatrics II and Essener Centre for Rare Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Julia Körholz (J)

Children's Department and University Centre for Rare Diseases (USE), University Hospital Dresden, Dresden, Germany.

Cordula Kiewert (C)

Department of Paediatrics II and Essener Centre for Rare Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

André Heinen (A)

Children's Department and University Centre for Rare Diseases (USE), University Hospital Dresden, Dresden, Germany.

Tanita Kretschmer (T)

Children's Department and University Centre for Rare Diseases (USE), University Hospital Dresden, Dresden, Germany.

Tobias Kurth (T)

Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Janna Mittnacht (J)

Centre for Child and Adolescent Medicine and and Centre for Rare Diseases, University Hospital Heidelberg, Heidelberg, Germany.

Christoph Schramm (C)

Martin Zeitz Centre for Rare Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Christoph Klein (C)

Dr von Hauner Children's Hospital, University Hospital and Munich Centre for Rare Diseases (M-ZSELMU), Ludwig-Maximilians-University Munich, Munich, Germany.

Holm Graessner (H)

Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tübingen, Germany.

Olaf Hiort (O)

Departments of Paediatrics, University Medical Centre Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.

Ania C Muntau (AC)

University Children's Hospital, University Medical Center Hamburg Eppendorf, Hamburg, Germany.

Annette Grüters (A)

Institute for Experimental Paediatric Endocrinology and Centre for Rare Diseases, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Georg F Hoffmann (GF)

Centre for Child and Adolescent Medicine and and Centre for Rare Diseases, University Hospital Heidelberg, Heidelberg, Germany.

Daniela Choukair (D)

Centre for Child and Adolescent Medicine and and Centre for Rare Diseases, University Hospital Heidelberg, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH